Cargando…
Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges
Neurofilament-light chain (Nf-L) is a non-specific early-stage biomarker widely studied in the context of neurodegenerative diseases (NDD) and traumatic brain injuries (TBI), which can be measured in biofluids after axonal damage. Originally measured by enzyme-linked immunosorbent assay (ELISA) in c...
Autores principales: | Coppens, Salomé, Lehmann, Sylvain, Hopley, Christopher, Hirtz, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380627/ https://www.ncbi.nlm.nih.gov/pubmed/37511382 http://dx.doi.org/10.3390/ijms241411624 |
Ejemplares similares
-
Neurofilament Light Chain Is a Promising Biomarker in Alcohol Dependence
por: Li, Yanfei, et al.
Publicado: (2021) -
Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients
por: Esselin, Florence, et al.
Publicado: (2022) -
Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022) -
A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer’s Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration
por: Das, Shreyasee, et al.
Publicado: (2022) -
Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson’s Disease
por: Pons, Marie-Laure, et al.
Publicado: (2022)